Evidence map›Paper›PMID 41600935›Full record

ArticleVaccines2025

Safety Evaluation of Large-Scale Administration of a Novel Human Diploid (SV-1) Cell Line-Derived Varicella Attenuated Live Vaccine in Children 7-12 Years Old.

Yuanyuan Zhu, Yurong Li, Jing Yu, Borong Xu, Xun Li, Ran Hu, Xiaozhe Song, Yonghong Sun, Dongsheng Liu, Yuan Ren and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuanyuan ZhuDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.ORCID 0000-0002-5380-1894
Yurong LiSinovac Holding Group Co., Ltd., Beijing 100085, China.ORCID 0000-0001-6851-0435
Jing YuDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Borong XuDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Xun LiDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Ran HuDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Xiaozhe SongDepartment of Immunization Program, Xuzhou Center for Disease Control and Prevention, Xuzhou 221006, China.
Yonghong SunDepartment of Immunization Program, Xuzhou Center for Disease Control and Prevention, Xuzhou 221006, China.
Dongsheng LiuDepartment of Immunization Program, Xuzhou Center for Disease Control and Prevention, Xuzhou 221006, China.
Yuan RenSinovac Holding Group Co., Ltd., Beijing 100085, China.
Xiang SunDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.ORCID 0000-0002-0030-7016
Zhiguo WangDepartment of Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.

Funding

Jiangsu Provincial Geriatric Health Research Project LKM2023005Opening Foundation of Key Laboratory JSHD 2022043
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse events following immunizationreal-world studysafety monitoringschool-aged childrenSV-1 cell linevaricella vaccine

Identifiers

PMID41600935
PMCPMC12846628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.